help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'REGAN, A. W.
Right arrow Articles by BERMAN, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'REGAN, A. W.
Right arrow Articles by BERMAN, J. S.

Am. J. Respir. Crit. Care Med., Volume 164, Number 12, December 2001, 2243-2247

Abnormal Pulmonary Granuloma Formation in Osteopontin-deficient Mice

ANTHONY W. O'REGAN, JASON M. HAYDEN, STEVEN BODY, LUCY LIAW, NIALL MULLIGAN, MARGO GOETSCHKES, and JEFFREY S. BERMAN

Pulmonary Center and Department of Pathology, Boston University School of Medicine, and the Center for Molecular Medicine, Maine Medical Center Research Institute, Boston, Massachusetts

Osteopontin is a novel cytokine that is expressed in pulmonary granulomatous disease such as sarcoidosis and tuberculosis. It can regulate macrophage and T cell migration, activation, and cytokine expression, yet its role in granuloma formation and evolution is unknown. We induced hypersensitivity pulmonary granulomas by embolizing Schistosoma mansoni eggs to the lungs of osteopontin-deficient (null mutant) mice and osteopontin-sufficient (wild-type control) mice. Granulomas from osteopontin-null animals were smaller at early time points and contained remarkably few macrophages and macrophage-derived epithelioid cells and giant cells. T cell accumulation was unaffected by osteopontin deficiency. These results demonstrate that osteopontin regulates macrophage accumulation during pulmonary granuloma formation, and may explain the impaired ability of osteopontin-deficient hosts to control mycobacterial disease.




This article has been cited by other articles:


Home page
 IOVSHome page
K.-i. Miyazaki, Y. Okada, O. Yamanaka, A. Kitano, K. Ikeda, S. Kon, T. Uede, S. R. Rittling, D. T. Denhardt, W. W.-Y. Kao, et al.
Corneal Wound Healing in an Osteopontin-Deficient Mouse
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1367 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Hashimoto, D. Sun, S. R. Rittling, D. T. Denhardt, and W. Young
Osteopontin-Deficient Mice Exhibit Less Inflammation, Greater Tissue Damage, and Impaired Locomotor Recovery from Spinal Cord Injury Compared with Wild-Type Controls
J. Neurosci., March 28, 2007; 27(13): 3603 - 3611.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. T. Hikita, B. P. Vistica, H. R. Jones, J. R. Keswani, M. M. Watson, V. R. Ericson, G. S. Ayoub, I. Gery, and D. O. Clegg
Osteopontin is proinflammatory in experimental autoimmune uveitis.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4435 - 4443.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
J. Sodek, A. P. Batista Da Silva, and R. Zohar
Osteopontin and Mucosal Protection
Journal of Dental Research, May 1, 2006; 85(5): 404 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. C. Wesselkamper, L. M. Case, L. N. Henning, M. T. Borchers, J. W. Tichelaar, J. M. Mason, N. Dragin, M. Medvedovic, M. A. Sartor, C. R. Tomlinson, et al.
Gene Expression Changes during the Development of Acute Lung Injury Role of Transforming Growth Factor {beta}
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1399 - 1411.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
K. Kawamura, K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki
Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation
Clin. Vaccine Immunol., January 1, 2005; 12(1): 206 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. S. Berman, D. Serlin, X. Li, G. Whitley, J. Hayes, D. C. Rishikof, D. A. Ricupero, L. Liaw, M. Goetschkes, and A. W. O'Regan
Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1311 - L1318.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. Morimoto, M. Inobe, C. Kimura, S. Kon, H. Diao, M. Aoki, T. Miyazaki, D. T. Denhardt, S. Rittling, and T. Uede
Osteopontin affects the persistence of {beta}-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms
Int. Immunol., March 1, 2004; 16(3): 477 - 488.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
T. Blom, A. Franzen, D. Heinegard, and R. Holmdahl
Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease"
Science, March 21, 2003; 299(5614): 1845a - 1845a.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  Membership Renewal